Anti-CD63 抗体 [EPR5702] - Late Endosome Marker
Anti-CD63 antibody [EPR5702] - Late Endosome Marker
- RabMAb
- Recombinant
- KO Validated
- Lab Essentials
- 詳細を見る
3
(6 Reviews)
|
(663 Publications)
Anti-CD63 antibody [EPR5702] - Late Endosome Marker (ab134045) is a rabbit monoclonal antibody detecting CD63 in Western Blot, IHC-P. Suitable for Human.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 380 publications
別名を表示する
CD63, MLA1, TSPAN30, CD63 antigen, Granulophysin, Lysosomal-associated membrane protein 3, Lysosome integral membrane protein 1, Melanoma-associated antigen ME491, OMA81H, Ocular melanoma-associated antigen, Tetraspanin-30, LAMP-3, Limp1, Tspan-30
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD63 antibody [EPR5702] - Late Endosome Marker (AB134045)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human melanoma tissue labelling CD63 with unpurified ab134045 at a dilution of 1/250.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD63 antibody [EPR5702] - Late Endosome Marker (AB134045)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human tonsil tissue labelling CD63 with purified ab134045 at 1/2000. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD63 antibody [EPR5702] - Late Endosome Marker (AB134045)
Immunohistochemical analysis of formalin fixed paraffin embedded human tonsil staining CD63 with ab134045 at a concentration of 0.1 µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.
ab134045 anti-CD63 [EPR5702] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual)
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD63 antibody [EPR5702] - Late Endosome Marker (AB134045)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human skeletal muscle tissue (negative control) labelling CD63 with purified ab134045 at 1/2000. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.
- WB
Lab
Western blot - Anti-CD63 antibody [EPR5702] - Late Endosome Marker (AB134045)
Anti-CD63 antibody [EPR5702] (ab134045) staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab134045 was shown to bind specifically to CD63. A band was observed at 30 kDa in wild-type HepG2 cell lysates with no signal observed at this size in CD63 knockout cell line ab280796 (knockout cell lysate ab283828). To generate this image, wild-type and CD63 knockout HepG2 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-CD63 antibody [EPR5702] - Late Endosome Marker (ab134045) at 1/1000 dilution
Lanes 1 - 4:
Western blot at 20 µg
Lanes 3 - 4:
Western blot - Human CD63 knockout Hep G2 cell lysate (ab283828)
Lanes 3 - 4:
Western blot - Human CD63 knockout Hep G2 cell line (<a href='/products/cell-lines/human-cd63-knockout-hep-g2-cell-line-ab280796'>ab280796</a>)
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Predicted band size: 26 kDa
Observed band size: 30 kDa
false
- WB
Lab
Western blot - Anti-CD63 antibody [EPR5702] - Late Endosome Marker (AB134045)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CD63 antibody [EPR5702] - Late Endosome Marker (ab134045) at 1/5000 dilution
Lane 1:
A375 whole cell lysate at 20 µg
Lane 2:
HL-60 whole cell lysate at 20 µg
Lane 3:
Human melanoma tissue lysate at 20 µg
Secondary
All lanes:
HRP-conjugated anti-rabbit IgG, specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 26 kDa
Observed band size: 30-65 kDa
false
- WB
Lab
Western blot - Anti-CD63 antibody [EPR5702] - Late Endosome Marker (AB134045)
Lanes 1 - 6 : Merged signal (red and green). Green - ab134045 observed at 26 kDa. Red - loading control, ab9484, observed at 37 kDa.
ab134045 was shown to specifically react with CD63 in wild-type HAP1 Brefeldin A treated cells as signal was lost in HAP1 Brefeldin A treated CD63 knockout cells. Wild-type and CD63 knockout samples were subjected to SDS-PAGE. ab134045 and ab9484 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CD63 antibody [EPR5702] - Late Endosome Marker (ab134045) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
Brefeldin A treated wild-type HAP1 whole cell lysate at 20 µg
Lane 3:
CD63 knockout HAP1 whole cell lysate at 20 µg
Lane 4:
Brefeldin A treated CD63 knockout HAP1 whole cell lysate at 20 µg
Lane 5:
HL60 whole cell lysate at 20 µg
Lane 6:
Human platelets whole cell lysate at 20 µg
Predicted band size: 26 kDa
false
- WB
Unknown
Western blot - Anti-CD63 antibody [EPR5702] - Late Endosome Marker (AB134045)
All lanes:
Western blot - Anti-CD63 antibody [EPR5702] - Late Endosome Marker (ab134045) at 1/1000 dilution
Lane 1:
Human platelet lysate at 10 µg
Lane 2:
Human melanoma lysate at 10 µg
Lane 3:
HL-60 lysate at 10 µg
Lane 4:
A375 lysate at 10 µg
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG at 1/2000 dilution
Predicted band size: 26 kDa
false
関連する標識済み抗体及び組成の異なる製品 (3)
-
Anti-CD63 antibody [EPR5702] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CD63 - Late Endosome Marker antibody [EPR5702]
-
Biotin Anti-CD63 antibody [EPR5702] - Late Endosome Marker
Reactivity data
製品の詳細
Product Specifications
Anti-CD63 antibody [EPR5702] - Late Endosome Marker (ab134045) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in IHC-P, WB in human samples.
Anti-CD63 antibody [EPR5702] - Late Endosome Marker (ab134045) specifically detects CD63 (UniProt ID: P08962; Molecular weight: 26kDa) and is sold in 100 µL and 1 mL selling sizes.
Quality and Validation
Abcam's high quality manufacturing and validation processes ensure Anti-CD63 antibody [EPR5702] - Late Endosome Marker (ab134045) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-CD63 antibody [EPR5702] - Late Endosome Marker (ab134045) has been confirmed by testing in knockout samples.
Anti-CD63 antibody [EPR5702] - Late Endosome Marker (ab134045) has been cited over 379 times in peer reviewed journals and is trusted by the scientific community.
Anti-CD63 antibody [EPR5702] - Late Endosome Marker (ab134045) has 5 independent reviews from customers.
Related Products
Conjugation-ready, carrier free format available for antibody clone EPR5702 - ab215821.
Antibody clone EPR5702 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647 (ab309976, ab316180).
Target Information
CD63, also known as LAMP3 or Granulophysin, is a member of the tetraspanin family and is widely expressed on the surface of various cells, including macrophages and lymphocytes. It plays a crucial role in the formation and release of exosomes. CD63 (Granulophysin) is highly expressed in various tumor cells and also impacts the tumor microenvironment (TME) by regulating cell communication. Additionally, CD63 facilitates the degradation of the extracellular matrix, aiding in tumor cell invasion and metastasis.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD63 participates in various cellular processes including membrane trafficking cell adhesion and signal transduction. It associates with integrins and other tetraspanins forming complexes that influence cellular adhesion and migration. Through its role in exosome formation CD63 contributes significantly to intercellular communication by facilitating the transfer of proteins lipids and RNA between cells.
Pathways
CD63 plays a role in pathways linked to cell proliferation and migration and immune response regulation. Within the integrin-mediated signaling pathway CD63 interacts with proteins such as integrins to promote cell adhesion and migration. CD63 also links to vesicle trafficking pathways collaborating with proteins involved in exocytosis and endocytosis which affect cell membrane restructuring and intracellular transport.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (663)
Recent publications for all applications. Explore the full list and refine your search
Bioengineering & translational medicine 10:e70025 PubMed41030280
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 26: PubMed41009408
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 13:1620648 PubMed40977891
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of extracellular vesicles 14:e70160 PubMed40955457
2025
Applications
Unspecified application
Species
Unspecified reactive species
Brazilian journal of otorhinolaryngology 91:101703 PubMed40916258
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:8186 PubMed40897707
2025
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 20:e0329985 PubMed40864638
2025
Applications
Unspecified application
Species
Unspecified reactive species
Discover oncology 16:1638 PubMed40864330
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 31:281 PubMed40849639
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 31:278 PubMed40819077
2025
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com